Soy, estrogen, and endometriosis: bridging nutritional research with clinical practice

Shelby Howard; Siobhán Howard; Laurel Stadtmauer

doi:10.1016/j.fertnstert.2025.09.008

Soy, estrogen, and endometriosis: bridging nutritional research with clinical practice

Shelby Howard, Siobhán Howard, Laurel Stadtmauer

Fertility and sterility · 2025 · vol. 124(5) , pp. 994–995 · doi:10.1016/j.fertnstert.2025.09.008 · PMID:40939711 · W4414105648

editorial OA: closed CC0

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

Daidzein-rich isoflavone aglycones inhibit cell growth and inflammation in endometriosis 2018

References (3)

Daidzein-rich isoflavone aglycones inhibit cell growth and inflammation in endometriosis via openalex
doi:10.1093/jn/133.3.956s via openalex
doi:10.3390/nu8060361 via openalex

Source provenance

europepmc: last seen: 2026-06-04T01:30:01.192114+00:00
openalex: last seen: 2026-05-11T06:24:00.257642+00:00
pubmed: last seen: 2026-05-29T00:30:59.300374+00:00

License: CC0 · commercial use OK

[1] Daidzein-rich isoflavone aglycones inhibit cell growth and inflammation in endometriosis 2018